UNSPSC 85921106: Medication management for substance abuse treatment, naltrexone

This classification denotes the group of activities that yields a substance abuse treatment intervention or procedure of medication management for substance abuse treatment, naltrexonemedication management for substance abuse treatment, naltrexone. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code HZ84ZZZ

UNSPSC 85921106 Medication management for substance abuse treatment, naltrexone is a Commodity code that does not align with the recent state and local opportunities posted under this designation. The source records show no solicitations for naltrexone or medication management for substance abuse treatment; instead, the opportunities span speech-language pathology staffing (Hillsborough County Public Schools, Florida), substance abuse treatment services and cognitive interventions for female offenders (Harris County Community Supervision & Corrections Department, Texas), cellular therapy lab software (UT Health San Antonio), outpatient rehabilitation outcome measures (San Mateo County), special education managed services (Griffin-Spalding County School System, Georgia), physical therapy for inmates (Bergen County, New Jersey), mental health services for probation employees (Sacramento County), and crisis intervention and victim advocacy services across multiple states. The code's nominal scope—medication management using naltrexone for substance use disorder treatment—appears to be a mismatch with the actual procurement activity tagged under it.

The one exception is Harris County Community Supervision & Corrections Department's Request for Statement of Qualifications (RFSQ) posted October 9, 2026 with responses due November 2, 2026, which does encompass substance abuse treatment services and cognitive interventions for female offenders in the Women Helping Ourselves Program, beginning February 1, 2027. However, this opportunity centers on comprehensive treatment services and evidence-based criminogenic interventions rather than on naltrexone or medication management specifically. The source provides no detail on whether medication management or naltrexone is included in the scope. Given the mismatch between the code's definition and the substantive procurement opportunities in the source, the code shows little relevant recent activity for naltrexone-specific medication management procurement at the state and local level.